UnitedHealth Group (NYSE:UNH) had its price target raised by Credit Suisse Group from $260.00 to $270.00 in a report published on Wednesday morning. Credit Suisse Group currently has an outperform rating on the healthcare conglomerate’s stock.
UNH has been the subject of several other reports. Zacks Investment Research raised UnitedHealth Group from a hold rating to a buy rating and set a $240.00 price objective for the company in a research report on Tuesday, April 3rd. Deutsche Bank increased their price objective on UnitedHealth Group to $260.00 and gave the company a buy rating in a research report on Wednesday, January 17th. Cantor Fitzgerald reissued a buy rating and issued a $235.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 16th. BMO Capital Markets increased their price objective on UnitedHealth Group from $14.50 to $275.00 and gave the company an outperform rating in a research report on Wednesday, January 17th. Finally, Royal Bank of Canada reissued a buy rating on shares of UnitedHealth Group in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The stock has a consensus rating of Buy and an average target price of $251.13.
Shares of UNH stock opened at $235.06 on Wednesday. UnitedHealth Group has a 12 month low of $166.65 and a 12 month high of $250.79. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.71. The company has a market cap of $228,136.20, a price-to-earnings ratio of 23.34, a P/E/G ratio of 1.36 and a beta of 0.77.
In other UnitedHealth Group news, insider Larry C. Renfro sold 22,184 shares of UnitedHealth Group stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the transaction, the insider now directly owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction on Monday, March 19th. The shares were sold at an average price of $224.36, for a total value of $2,243,600.00. Following the transaction, the director now directly owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 77,019 shares of company stock valued at $17,879,133. 0.89% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently modified their holdings of UNH. Maverick Capital Ltd. bought a new position in shares of UnitedHealth Group during the second quarter valued at $4,048,000. Kingdon Capital Management L.L.C. bought a new position in shares of UnitedHealth Group during the second quarter valued at $13,841,000. Arrowstreet Capital Limited Partnership increased its stake in shares of UnitedHealth Group by 30.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,303,068 shares of the healthcare conglomerate’s stock valued at $241,615,000 after buying an additional 300,744 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in shares of UnitedHealth Group by 3,881.4% in the second quarter. Tower Research Capital LLC TRC now owns 6,211 shares of the healthcare conglomerate’s stock valued at $1,152,000 after buying an additional 6,055 shares in the last quarter. Finally, Coldstream Capital Management Inc. increased its stake in shares of UnitedHealth Group by 37.8% in the second quarter. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate’s stock valued at $315,000 after buying an additional 466 shares in the last quarter. 86.78% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group (UNH) Price Target Raised to $270.00” was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://weekherald.com/2018/04/21/unitedhealth-group-unh-price-target-raised-to-270-00.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.